Chubb Stock Jumps After Buffett's Berkshire Takes a Stake
Chubb stock is up on news Warren Buffett's holding company Berkshire Hathaway built a position in the insurance firm. Here's what you need to know.
Chubb (CB) stock is trading comfortably higher Thursday on news Warren Buffett's Berkshire Hathaway (BRK.B) holding company built a new position in the insurance firm.
In the most recent Securities and Exchange Commission (SEC) Form 13-F filing that revealed all the stocks Buffett is buying and selling, released late Wednesday, Berkshire Hathaway disclosed that it bought 25.9 million CB shares. This was worth a market value of roughly $6.7 billion as of March 31, 2024, or a 6.1% stake in the company.
Berkshire Hathaway began buying Chubb shares in the third quarter of 2023 and received permission from regulators to keep the holding confidential until it was done building its stake, according to CNBC.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
At the end of Q1 2024, Chubb was the ninth largest position in the Berkshire Hathaway equity portfolio, with a 2.0% weight.
The property and casualty insurer fits well within the Berkshire wheelhouse. Not only is Berkshire the parent company of insurance firms GEICO and Alleghany, but there are several large-cap financial stocks included in the equity portfolio, such as Bank of America (BAC) and Aon (AON).
The news of Berkshire's position in Chubb comes just weeks after the holding company's annual meeting, where Buffett said it reduced its stake in Apple (AAPL) by 13%. Even after this reduction Apple is still Berkshire's largest position, representing about 40% of the portfolio at the end of Q1 2024.
Where does Chubb stand with analysts?
Analysts are positive on the insurance giant. According to S&P Global Market Intelligence, the consensus analyst target price for CB stock is $268.36, representing implied upside of more than 2% to current levels. Meanwhile, the consensus recommendation is Buy.
Independent research firm Argus Research is one of the more bullish outfits on Chubb stock with a Buy rating and a recently increased price target.
"A provider of property and casualty and health/life insurance, as well as reinsurance, Chubb benefits from a strong brand, an experienced management team, and a healthy balance sheet," Argus said in a May 10 report. "We are raising our target price to $280 from $270."
The $280 price target represents implied upside of about 7% to current levels.
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Nvidia Stock Is Joining the Dow. Is It Time to Buy?
Nvidia will replace Intel in the Dow Jones Industrial Average this Friday. What does it mean for the stock?
By Dan Burrows Published
-
Tesla Stock Extends Losing Streak Ahead of Election Day
Tesla stock is headed toward its sixth straight loss Monday and Wall Street is staying on the sidelines. Here's why.
By Joey Solitro Published
-
Nvidia Stock Is Joining the Dow. Is It Time to Buy?
Nvidia will replace Intel in the Dow Jones Industrial Average this Friday. What does it mean for the stock?
By Dan Burrows Published
-
Tesla Stock Extends Losing Streak Ahead of Election Day
Tesla stock is headed toward its sixth straight loss Monday and Wall Street is staying on the sidelines. Here's why.
By Joey Solitro Published
-
Why Constellation Energy Stock Is Sliding After an Earnings Beat
Constellation Energy stock is lower Monday as a regulatory decision offsets the utility company's solid third-quarter earnings results.
By Joey Solitro Published
-
Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data
Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.
By Joey Solitro Published
-
How to Sell Your Business With No Regrets
The key to a successful exit: You've got to be prepared. So, start now by maximizing profitability, planning for succession and avoiding the dreaded five D's.
By Nick Guida, Investment Adviser Representative Published
-
The Bare Necessities of Buying Pet Insurance
Pet insurance can help put you at ease over the health of your furry friends. Here's what to look for when shopping around for a policy.
By Joelle Spear, CFP® Published
-
Should You Buy These Covered-Call Funds?
Covered-call ETFs are popular but come with plenty of caveats.
By Andrew Tanzer Published
-
Is It Too Late to Do a Roth Conversion if You're Retired?
The short answer is: Not at all. Roth conversions can be great tax-saving strategies … for the right people. Are you a good candidate?
By Arrin Wray Published